Cargando…

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention

Detalles Bibliográficos
Autores principales:	Islam, Bianca N., Browning, Darren D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188491/ https://www.ncbi.nlm.nih.gov/pubmed/30187889 http://dx.doi.org/10.18632/aging.101545

Ejemplares similares

A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice
por: Lee, Avelina, et al.
Publicado: (2023)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Cancer Chemoprevention
por: Amin, Amr, et al.
Publicado: (2012)

Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management?
por: Mondaini, Nicola
Publicado: (2020)

Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
por: Kang, Shin-Wook
Publicado: (2012)

Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?
por: Grandin, E. Wilson, et al.
Publicado: (2021)

Chemoprevention of metastasis
por: Emenaker, Nancy J., et al.
Publicado: (2014)

Decision aids for breast cancer chemoprevention
por: Juraskova, Ilona, et al.
Publicado: (2013)

Dietary Agents in Cancer Chemoprevention and Treatment
por: Raffoul, Julian J., et al.
Publicado: (2012)

Current and Future Cancer Chemoprevention Strategies
por: Santibanez, Juan F., et al.
Publicado: (2023)

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer
por: Ammar, Lina, et al.
Publicado: (2023)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

COVID-19 chemoprevention
por: Cruz, Cintia, et al.
Publicado: (2021)

Colon cancer chemoprevention with ginseng and other botanicals.
por: Wargovich, M J
Publicado: (2001)

Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
por: Hutchings, David Charles, et al.
Publicado: (2018)

Using PDE5 inhibitors for the prevention and treatment of colorectal cancer
por: Browning, Darren D
Publicado: (2015)

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007)

Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
por: Iovanna, Juan, et al.
Publicado: (2010)

Chemopreventive and metabolic effects of inulin on colon cancer development
por: Hijová, Emília, et al.
Publicado: (2013)

Jacalin Has Chemopreventive Effects on Colon Cancer Development
por: Geraldino, Thais Herrero, et al.
Publicado: (2017)

Medicinal Plants and Natural Active Compounds for Cancer Chemoprevention/Chemotherapy
por: Zaid, Hilal, et al.
Publicado: (2017)

AB030. Evolution of phosphodiesterase type 5 inhibitors
por: Moon, Du Geon
Publicado: (2016)

The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic History
por: Elhwuegi, AS
Publicado: (2016)

The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue
por: Zucchi, A., et al.
Publicado: (2019)

COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
por: Gheorghiu, Oana Ramona Cătălina, et al.
Publicado: (2023)

Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver
por: Halverscheid, Leonie, et al.
Publicado: (2009)

The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
por: Peixoto, Christina Alves, et al.
Publicado: (2015)

Pharmacophore elucidation and molecular docking studies on phosphodiesterase-5 inhibitors
por: Radwan, Awwad Abdoh
Publicado: (2015)

Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia
por: Alshahrani, Saad, et al.
Publicado: (2016)

Contribution of sewage to occurrence of phosphodiesterase-5 inhibitors in natural water
por: Hong, Youngmin, et al.
Publicado: (2021)

Phosphodiesterase Type 5 Inhibitors and sudden sensorineural hearing loss
por: Barreto, Monique Antunes de Souza Chelminski, et al.
Publicado: (2015)

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
por: ElHady, Ahmed K., et al.
Publicado: (2023)

Coupling of conformational dynamics and inhibitor binding in the phosphodiesterase‐5 family
por: Tripathi, Shubhandra, et al.
Publicado: (2023)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer
por: Grbčić, Petra, et al.
Publicado: (2020)

Chemoprevention of Colorectal Cancer by Dietary Compounds
por: Costea, Teodora, et al.
Publicado: (2018)

Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis
por: Machen, G. Luke, et al.
Publicado: (2017)

The Association Between Phosphodiesterase-5 Inhibitors and Colorectal Cancer in a National Cohort of Patients
por: Sutton, S. Scott, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_thdavqqrmqr5bja57l23iitn2o